BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 31439264)

  • 1. MRI in differentiating malignant versus benign portal vein thrombosis in patients with hepatocellular carcinoma: Value of post contrast imaging with subtraction.
    Gawande R; Jalaeian H; Niendorf E; Olgun D; Krystosek L; Rubin N; Spilseth B
    Eur J Radiol; 2019 Sep; 118():88-95. PubMed ID: 31439264
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Usefulness of conventional MRI sequences and diffusion-weighted imaging in differentiating malignant from benign portal vein thrombus in cirrhotic patients.
    Sandrasegaran K; Tahir B; Nutakki K; Akisik FM; Bodanapally U; Tann M; Chalasani N
    AJR Am J Roentgenol; 2013 Dec; 201(6):1211-9. PubMed ID: 24261359
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diffusion-Weighted MRI of Malignant versus Benign Portal Vein Thrombosis.
    Ahn JH; Yu JS; Cho ES; Chung JJ; Kim JH; Kim KW
    Korean J Radiol; 2016; 17(4):533-40. PubMed ID: 27390544
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contrast-enhanced ultrasound in differentiating malignant from benign portal vein thrombosis in hepatocellular carcinoma.
    Tarantino L; Ambrosino P; Di Minno MN
    World J Gastroenterol; 2015 Aug; 21(32):9457-60. PubMed ID: 26327753
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differentiation of bland from neoplastic thrombus of the portal vein in patients with hepatocellular carcinoma: application of susceptibility-weighted MR imaging.
    Li C; Hu J; Zhou D; Zhao J; Ma K; Yin X; Wang J
    BMC Cancer; 2014 Aug; 14():590. PubMed ID: 25123782
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic Role of Contrast-enhanced Ultrasound in the Discrimination of Malignant Portal Vein Thrombosis in Patients With Hepatocellular Carcinoma.
    Kwon JH; Yoo SH; Nam SW; Lee YJ; Shin YR
    Anticancer Res; 2020 Aug; 40(8):4351-4363. PubMed ID: 32727763
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differentiation of malignant thrombus from bland thrombus of the portal vein in patients with hepatocellular carcinoma: application of diffusion-weighted MR imaging.
    Catalano OA; Choy G; Zhu A; Hahn PF; Sahani DV
    Radiology; 2010 Jan; 254(1):154-62. PubMed ID: 20032150
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Portal Vein Thrombosis in Patients with Hepatocellular Carcinoma: Diagnostic Accuracy of Gadoxetic Acid-enhanced MR Imaging.
    Kim JH; Lee JM; Yoon JH; Lee DH; Lee KB; Han JK; Choi BI
    Radiology; 2016 Jun; 279(3):773-83. PubMed ID: 26780538
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic performances of intravoxel incoherent motion and conventional diffusion-weighted imaging in the differential diagnosis of benign and malignant portal vein thrombus.
    Aumann EK; Server S; Koyuncu Sokmen B; Oz A; Namal E; Gurcan NI; Balci NC; Tokat Y
    Abdom Radiol (NY); 2018 Sep; 43(9):2270-2276. PubMed ID: 29411058
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distinguishing Tumor From Bland Portal Vein Thrombus in Liver Transplant Candidates With Hepatocellular Carcinoma: the A-VENA Criteria.
    Sherman CB; Behr S; Dodge JL; Roberts JP; Yao FY; Mehta N
    Liver Transpl; 2019 Feb; 25(2):207-216. PubMed ID: 30246323
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatocellular carcinoma presenting as an incidental isolated malignant portal vein thrombosis.
    Poddar N; Avezbakiyev B; He Z; Jiang M; Gohari A; Wang JC
    J Gastrointest Cancer; 2012 Sep; 43(3):486-9. PubMed ID: 21190093
    [TBL] [Abstract][Full Text] [Related]  

  • 12. B-mode and contrast enhanced ultrasound guided biopsy of portal vein thrombosis. Value in the diagnosis of occult hepatocellular carcinoma in liver cirrhosis.
    Sparchez Z; Radu P; Zaharia T; Kacso G; Diaconu B; Grigorescu I; Badea R
    Med Ultrason; 2010 Dec; 12(4):286-94. PubMed ID: 21210013
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnosis of benign and malignant portal vein thrombosis in cirrhotic patients with hepatocellular carcinoma: color Doppler US, contrast-enhanced US, and fine-needle biopsy.
    Tarantino L; Francica G; Sordelli I; Esposito F; Giorgio A; Sorrentino P; de Stefano G; Di Sarno A; Ferraioli G; Sperlongano P
    Abdom Imaging; 2006; 31(5):537-44. PubMed ID: 16865315
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MR imaging in diffuse-type hepatocellular carcinoma with synchronous portal vein thrombi.
    Halıloğlu N; Özkavukcu E; Erden A; Erden İ
    Turk J Gastroenterol; 2011; 22(2):158-64. PubMed ID: 21796552
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnosis of portal vein thrombosis discontinued with liver tumors in patients with liver cirrhosis and tumors by contrast-enhanced US: a pilot study.
    Song ZZ; Huang M; Jiang TA; Zhao QY; Yao L; Mou Y; Zhao JK; Ao JY; Chen F; Chen Y
    Eur J Radiol; 2010 Aug; 75(2):185-8. PubMed ID: 19464131
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Janus Kinase-2 Mutation Associated Portal Vein Thrombosis Complicating Liver Cirrhosis and Hepatocellular Carcinoma.
    Rabie H; Othman W; Elsabaawy DM; Elshemy EE; Abdelmageed N; Khalaf FA; Bedair HM
    Asian Pac J Cancer Prev; 2021 Jan; 22(1):267-275. PubMed ID: 33507708
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Criteria for diagnosing benign portal vein thrombosis in the assessment of patients with cirrhosis and hepatocellular carcinoma for liver transplantation.
    Piscaglia F; Gianstefani A; Ravaioli M; Golfieri R; Cappelli A; Giampalma E; Sagrini E; Imbriaco G; Pinna AD; Bolondi L;
    Liver Transpl; 2010 May; 16(5):658-67. PubMed ID: 20440775
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Limited value of diffusion-weighted MR imaging for differentiating bland from malignant portal venous thrombi.
    Yu JS; Chung JJ; Kim JH; Kim KW
    Radiology; 2010 Aug; 256(2):673-4; author reply 674. PubMed ID: 20656851
    [No Abstract]   [Full Text] [Related]  

  • 19. Comparison of MRI pulse sequences for prediction of size of hepatocellular carcinoma at explant evaluation.
    Seuss CR; Kim MJ; Triolo MJ; Hajdu CH; Rosenkrantz AB
    AJR Am J Roentgenol; 2014 Aug; 203(2):300-5. PubMed ID: 25055263
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of HCC response to locoregional therapy: Validation of MRI-based response criteria versus explant pathology.
    Gordic S; Corcuera-Solano I; Stueck A; Besa C; Argiriadi P; Guniganti P; King M; Kihira S; Babb J; Thung S; Taouli B
    J Hepatol; 2017 Dec; 67(6):1213-1221. PubMed ID: 28823713
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.